DNA vaccine
Showing 1 - 25 of >10,000
Vaccine Reaction Trial in Cincinnati (Venezuelan Equine Encephalitis DNA Vaccine, PharmaJet Stratis Needle-free Injection
Not yet recruiting
- Vaccine Reaction
- Venezuelan Equine Encephalitis DNA Vaccine
- +2 more
-
Cincinnati, OhioVelocity Clinical Research
Aug 15, 2023
COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))
Recruiting
- COVID-19
- SARS-CoV-2 DNA Vaccine (ICCOV)
-
Wong Chuk Hang, Hong KongGleneagles Hospital Hong Kong
Jun 16, 2023
COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)
Not yet recruiting
- COVID-19 Respiratory Infection
- COVID-19 Vaccine Adverse Reaction
- DNA vaccine OC-007
- Placebo
-
Stockholm, Region Stockholm, SwedenPhase I Study Unit, Karolinska University Hospital
Jan 13, 2023
HSIL of Cervix Trial in Heze (NWRD08)
Recruiting
- HSIL of Cervix
- NWRD08
-
Heze, Shandong, ChinaHeze Municipal Hospital
Jun 6, 2023
Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation
Not yet recruiting
- Unmethylated Glioblastoma
- Personalized Neoantigen DNA vaccine
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 14, 2023
Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,
Recruiting
- Castration-resistant Prostate Cancer
- +2 more
- pTVG-HP
- +2 more
-
Saint Louis, Missouri
- +1 more
Nov 21, 2022
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)
Completed
- Metastatic Hormone-Sensitive Prostate Cancer
- PROSTVAC-V
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 3, 2022
Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,
Active, not recruiting
- Triple Negative Breast Cancer
- +3 more
- Durvalumab
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Hantaan Virus Nephropathy, Puumala Virus Nephropathy Trial in Silver Spring (Hataan DNA Vaccine/Puumala DNA Vaccine)
Recruiting
- Hantaan Virus Nephropathy
- Puumala Virus Nephropathy
- Hataan DNA Vaccine/Puumala DNA Vaccine
-
Silver Spring, MarylandClinical Trials Center, Walter Reed Army Institute of Reserach
Feb 16, 2022
HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
-
Los Angeles, California
- +1 more
Apr 4, 2022
Relapsed Neuroblastoma Trial in Minsk (DNA vaccine, Salmonella oral vaccine, Lenalidomide)
Recruiting
- Relapsed Neuroblastoma
- DNA vaccine
- +2 more
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Mar 1, 2022
Covid19 Trial in Hong Kong (SARS-CoV-2 DNA Vaccine, Matching )
Recruiting
- Covid19
- SARS-CoV-2 DNA Vaccine
- Matching placebo
-
Hong Kong, Hong KongHKU Phase 1 Clinical Trials Centre
Jan 26, 2022
Breast Cancer, Breast Carcinoma, Malignant Tumor of Breast Trial in Saint Louis, Columbus (Mammaglobin-A DNA Vaccine, Optional
Recruiting
- Breast Cancer
- +2 more
- Mammaglobin-A DNA Vaccine
- Optional biopsy
-
Saint Louis, Missouri
- +1 more
Jan 26, 2022
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
HIV Trial in Birmingham, San Francisco, Seattle (pGA2/JS2 Plasmid DNA Vaccine)
Completed
- HIV Infections
- pGA2/JS2 Plasmid DNA Vaccine
-
Birmingham, Alabama
- +3 more
Oct 13, 2021
HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)
Active, not recruiting
- HIV Infections
- Env-C Plasmid DNA
- +6 more
-
Kericho, KenyaKenya Medical Research Institute/Walter Reed Project, Clinical R
Feb 25, 2022
Hantavirus Pulmonary Infection, Immunisation Trial in Cincinnati (Andes virus DNA vaccine, Placebo)
Completed
- Hantavirus Pulmonary Infection
- Immunisation
- Andes virus DNA vaccine
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center - Infectious Disea
Sep 16, 2021
Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)
Completed
- Sars-CoV-2 Infection
- Alveavax-v1.2
- Janssen Ad26.COV2.S
-
Bloemfontein, Free State, South Africa
- +7 more
May 2, 2023
HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)
Active, not recruiting
- HIV Infections
- env (A,B,C,A/E)/gag (C) DNA Vaccine
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2022
HIV Trial in United States (PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo)
Completed
- HIV Infections
- PENNVAX®-GP HIV-1 DNA vaccine
- +2 more
-
Decatur, Georgia
- +3 more
Oct 13, 2021
SARS-CoV-2 Trial in Worldwide (Covigenix VAX-001 , Covigenix VAX-001)
Recruiting
- SARS-CoV-2
- Covigenix VAX-001 placebo
- Covigenix VAX-001
-
Ouagadougou, Burkina Faso
- +4 more
Jul 23, 2022